FTC Pauses Challenge to Amgen’s $27.8 Billion Deal for Horizon Therapeutics
Wall Street Journal
The move gives the agency time to weigh a settlement that would allow the deal to close with conditions.
Understanding current events through the lenses of the past and future.
Wall Street Journal
The move gives the agency time to weigh a settlement that would allow the deal to close with conditions.